Sarepta Therapeutics SRPT announced that it has sold at least $174 million worth of its equity investment in Arrowhead Pharmaceuticals ARWR to help fund a milestone payment to the latter. Shares of ...

The Medicare Payment Plan lets you cut up your Part D drug payments and spread them through the entire year. 2025 has been a busy year as some of the Inflation Reduction Act initiatives have taken ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The ...

REDMOND, Wash., Oct. 13, 2025 /PRNewswire/ -- SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-Breast01 study (NCT06926868) ...